These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 2571544)
1. Lack of an association between polymorphisms of the T-cell receptor alpha-chain and ulcerative colitis. Randolph LM; Toyoda H; McElree CK; Shanahan F; Targan SR; Rotter JI Gastroenterology; 1989 Nov; 97(5):1115-20. PubMed ID: 2571544 [TBL] [Abstract][Full Text] [Related]
3. Restriction fragment length polymorphism analysis of T-cell receptor genes in inflammatory bowel disease. Katakura S; Einarsson K; Hammarström L; Smith CI Scand J Gastroenterol; 1989 Apr; 24(3):381-4. PubMed ID: 2567531 [TBL] [Abstract][Full Text] [Related]
4. Distribution of an NcoI polymorphism in the lymphotoxin alpha gene in Dutch patients with inflamatory bowel diseases. Xia B; Bouma G; Grusius JB; Meuwissen SG; Pena AS Chin Med J (Engl); 1995 Oct; 108(10):739-42. PubMed ID: 8565658 [TBL] [Abstract][Full Text] [Related]
5. Polymorphism of the promoter region of C-509T of transforming growth factor-beta1 gene and ulcerative colitis. Tamizifar B; Bagheri-Lankarani K; Naeemi S; Rismankar-Zadeh M; Taghavi A; Ghaderi A Arch Iran Med; 2007 Apr; 10(2):171-5. PubMed ID: 17367219 [TBL] [Abstract][Full Text] [Related]
6. T cell antigen receptor V gene usage. Increases in V beta 8+ T cells in Crohn's disease. Posnett DN; Schmelkin I; Burton DA; August A; McGrath H; Mayer LF J Clin Invest; 1990 Jun; 85(6):1770-6. PubMed ID: 1971828 [TBL] [Abstract][Full Text] [Related]
7. Investigation of IL23R, JAK2, and STAT3 gene polymorphisms and gene-gene interactions in Crohn's disease and ulcerative colitis in a Turkish population. Can G; Tezel A; Gürkan H; Tozkır H; Ünsal G; Soylu AR; Ümit HC Turk J Gastroenterol; 2016 Nov; 27(6):525-536. PubMed ID: 27852544 [TBL] [Abstract][Full Text] [Related]
8. [Polymorphism of the microsatellites and tumor necrosis factor genes in chronic inflammatory bowel diseases]. Heresbach D; Ababou A; Bourienne A; Alizadeh M; Quelvennec E; Pagenault M; Dabadie A; Berre NH; Campion JP; Launois B; Gosselin M; Genetet B; Bretagne JF; Semana G Gastroenterol Clin Biol; 1997; 21(8-9):555-61. PubMed ID: 9587492 [TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Török HP; Glas J; Tonenchi L; Mussack T; Folwaczny C Clin Immunol; 2004 Jul; 112(1):85-91. PubMed ID: 15207785 [TBL] [Abstract][Full Text] [Related]
10. Dopamine D2 receptor polymorphisms in inflammatory bowel disease and the refractory response to treatment. Magro F; Cunha E; Araujo F; Meireles E; Pereira P; Dinis-Ribeiro M; Veloso FT; Medeiros R; Soares-da-Silva P Dig Dis Sci; 2006 Nov; 51(11):2039-44. PubMed ID: 16977509 [TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase-2 gene polymorphisms are associated with ulcerative colitis and Crohn's disease in Turkish Population. Can G; Tezel A; Gürkan H; Can H; Yılmaz B; Ünsal G; Soylu AR; Ümit HC Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):489-98. PubMed ID: 25744728 [TBL] [Abstract][Full Text] [Related]
12. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease. Ozen SC; Dagli U; Kiliç MY; Törüner M; Celik Y; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM J Gastroenterol; 2006 Apr; 41(4):304-10. PubMed ID: 16741608 [TBL] [Abstract][Full Text] [Related]
13. [Susceptibility genetic variants in Hungarian morbus Crohn and ulcerative colitis patients]. Magyari L; Melegh B Orv Hetil; 2009 Jan; 150(2):81-8. PubMed ID: 19103559 [TBL] [Abstract][Full Text] [Related]
14. Polymorphism in human T cell receptor alpha chain variable region genes. Grier AH; Mitchell MP; Robinson MA Exp Clin Immunogenet; 1990; 7(1):34-42. PubMed ID: 1971756 [TBL] [Abstract][Full Text] [Related]
15. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Stokkers PC; van Aken BE; Basoski N; Reitsma PH; Tytgat GN; van Deventer SJ Gut; 1998 Jul; 43(1):33-9. PubMed ID: 9771403 [TBL] [Abstract][Full Text] [Related]
16. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412 [TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab. Pierik M; Vermeire S; Steen KV; Joossens S; Claessens G; Vlietinck R; Rutgeerts P Aliment Pharmacol Ther; 2004 Aug; 20(3):303-10. PubMed ID: 15274667 [TBL] [Abstract][Full Text] [Related]
19. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Mansfield JC; Holden H; Tarlow JK; Di Giovine FS; McDowell TL; Wilson AG; Holdsworth CD; Duff GW Gastroenterology; 1994 Mar; 106(3):637-42. PubMed ID: 8119534 [TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of systemic lupus erythematosus: association with a T cell receptor restriction fragment length polymorphism in Japanese patients. Morito F; Hiida M; Ohta A; Yamaguchi M Intern Med; 1992 Aug; 31(8):998-1003. PubMed ID: 1362100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]